China updates pharmacopoeia; India harmonizes

The 2010 edition of China's Pharmacopoeia is set to hit the streets October 1. Some 40 percent of the new edition encompasses "new types of drugs," according to a report.

The update is expected to improve the international competitiveness of drugs made in China, says a government official in the report. It includes "improvements" on 70 percent of existing medications. The new edition also targets drugmakers that have "advanced technology and quality control."

Separately, India's pharmacopoeia commission says it wants to harmonize chapters with global standards set by the Pharmacopoeial Discussion Group. The commission met recently with United States Pharmacopoeia representatives regarding plans to align the Indian pharmacopeia with those of the U.S., Europe and Japan.

- here's the China's pharmacopoeia article
- see this article on India's efforts


Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.